
Arthur A. Levin
Insider
- 2024
- Jun 5, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Arthur A. Levin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Adrian R. Krainer - $3.90M in STOK purchases and sales in the last 12 months
- Barry Ticho - $1.88M in STOK purchases and sales in the last 12 months
- Jonathan Allan - $1.20M in STOK purchases and sales in the last 12 months
- Sarah Boyce - $1.04M in RNAM purchases and sales in the last 12 months
- Edward M. Md Kaye - $934K in STOK purchases and sales in the last 12 months
- W. Michael Flanagan - $473K in RNAM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arthur A. Levin?
Arthur A. Levin is a corporate insider of Stoke Therapeutics, Inc. (STOK). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Arthur A. Levin last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 12 filings going back to 2024.
Has Arthur A. Levin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($5.64M) across all tracked filings.